Clinical Trial Update: Effects of Nesiritide in Pediatric Patients With Heart Failure [NA]

View source ↗

Summary

The pediatric trial evaluating Nesiritide for heart failure (NCT00166010) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Emory University | Conditions: Heart Failure, Ventricular Dysfunction | NA | Status: WITHDRAWN